Paracetamol 125 & 250 Forrester 125 mg, 250 mg Suppositories
PDF Leaflet Revision Date: 01 August 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Relief of mild to moderate pain and fever when oral therapy is not feasible.
Dosage (summary)
10-15 mg/kg body weight; max 60 mg/kg/day; 125 mg for infants, 250 mg for children.
Onset of Action / Duration
Onset: 1.5-2.5 hours, Duration: 6-8 hours
Special Populations
- Hepatic insufficiency
- Mild renal insufficiency
- Severe renal insufficiency
- Elderly patients
Pregnancy & Breastfeeding
Use at lowest effective dose; safe during breastfeeding.
Key Drug Interactions
- Increased hepatotoxicity with alcohol and enzyme inducers
- Enhanced anticoagulant effect with warfarin
- Neutropenia risk with zidovudine
Contraindications
- Hypersensitivity to paracetamol
Common side effects
- Fatigue
- Headache
- Hypersensitivity reactions
Counselling Points
- Do not exceed recommended dose
- Consult if symptoms persist beyond 3 days
- Store out of reach of children
Serious warnings
- Risk of severe liver damage in overdose
- Use with caution in liver and kidney impairment
Important Disclaimer
The Paracetamol 125 & 250 Forrester 125 mg, 250 mg Suppositories professional information leaflet below is the property of Forrester Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
